HemoShear Therapeutics hemoshear.com


Public list: BIO 2016 (619) Pharma Startups (6570)

HemoShear Therapeutics discovers biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-TX, enables the company to create best-in-class, biological human disease models to uncover and explain the underlying mechanisms of disease, translate those discoveries into drug candidates, and predict which drug candidates will treat patients successfully.

HemoShear Therapeutics discovers biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-TX, enables the company to create best-in-class, biologic...Show all

Company (Alive / Active)

All investors data 8 Investors

Phone: 434-872-0196

Fax:

501 Locust Avenue
Suite 301
 Charlottesville, 22902
 Virginia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
HemoShear Therapeutics $26.3M Apr 8, 2020
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related HemoShear Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
National Heart Lung and Blood InstituteGovernmentBethesda, Maryland, United StatesGrant - II, Grant
CIT GAP FundsVenture CapitalHerndon, Virginia, United StatesOther Investors
National Institutes of HealthGovernmentBethesda, Maryland, United StatesGrant - II, Grant
National Organization for Rare DisordersNon-Profit FoundationDanbury, Connecticut, United StatesGrant - III
Paycheck Protection ProgramGovernmentWashington, DC, United StatesLoan
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
In vitro model for pathological or physiologic conditions May 19, 2017 Nov 17, 2020 Patent
In vitro model for pathological or physiologic conditions Nov 18, 2016 Dec 24, 2019 Patent
In vitro model for a tumor microenvironment Apr 10, 2017 Mar 05, 2019 Patent
In vitro model for pathological or physiologic conditions Apr 18, 2013 May 23, 2017 Patent
In vitro model for a tumor microenvironment Oct 21, 2014 Apr 11, 2017 Patent
See all 10 patents